By: Benzinga
February 26, 2013 at 16:17 PM EST
NuVasive Announces First Patient in Japan Treated with XLIF(R) Technique
NuVasive, Inc. (NASDAQ: NUVA ), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is proud to announce that the very first eXtreme Lateral Interbody Fusion (XLIF(R)) procedures were performed yesterday and today at two different hospitals in Japan. NuVasive has received regulatory Shonin approval for
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here